Skip to search formSkip to main contentSkip to account menu

JD5037

Known as: JD-5037 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PyrazolesSulfonamides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
SUN-665 Peripheral CB1R Blocker Improves Metabolism in Diet Induced Obese Mice Independent of Hepatic FGF21
Abstract Obesity is associated with an overactive endocannabinoid system, and selective blockade of CB1R in peripheral tissues… 
2017
2017
Pharmacological comparison of traditional and non-traditional cannabinoid receptor 1 blockers in rodent models in vivo
Review
2017
Review
2017
The brain strikes back: Hypothalamic targets for peripheral CB1 receptor inverse agonism
2017
2017
Synthesis of S-2-((S)-3-(4-chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamido)-3-(methyl-d3 )butanamide-d5 , octadeuterated JD5037.
JD5037 (1) is a potent and selective, peripherally acting inverse agonist of the cannabinoid (CB1 R) receptor. Peripheral CB1… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)